跳至主要内容
临床试验/NCT05543226
NCT05543226尚未招募4 期

The Effect of PHGG-rich Enteral Nutrition to on the Infection in Liver Transplant Recipients: A Prospective, Double-blind, Randomized Controlled Study

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University0 个研究点目标入组 136 人开始时间: 2022年10月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
尚未招募
入组人数
136
主要终点
Incidence of infections after liver transplantation

研究概览

简要总结

To known the effect of PHGG-rich enteral nutrition to on the infection in liver transplant recipients

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • liver transplant recipients
  • age from 18 to 80 years old
  • APACHE II score >12
  • There is an indication for enteral nutrition and it is expected to require oral or tube feeding for more than 7 days
  • there is no intra-abdominal infection or bloodstream infection

排除标准

  • Severe cardiac, kidney and lung dysfunction
  • bowel obstruction, intestinal perforation, intestinal leakage before operation
  • Roux and Y anastomosis during liver transplant

研究组 & 干预措施

PHGG

Experimental

干预措施: PHGG-rich enteral nutrtiion (Drug)

without PHGG

Placebo Comparator

干预措施: PHGG-rich enteral nutrtiion (Drug)

结局指标

主要结局

Incidence of infections after liver transplantation

时间窗: 30 days

the incidence of infections after 30 days of the liver transplantation

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验